[1]
2025. Periplocin improves the sensitivity of oxaliplatin-resistant hepatocellular carcinoma cells by inhibiting M2 macrophage polarization. Biomolecules and Biomedicine. 25, 4 (Mar. 2025), 857–868. DOI:https://doi.org/10.17305/bb.2024.10928.